Artificial Intelligence
Cradle
An AI protein engineering software company whose enterprise-grade platform serves six of the top 25 global pharma companies across more than 50 R&D programs. Cradle raised a $73 million Series B to advance its AI protein engineering software, with customers using the platform to speed up early R&D projects by up to 12x and reduce costs by up to 90%; recent case studies include improving a Staphylococcus aureus vaccine's thermostability by 2.5°C in a single optimization round, seven times faster than rational design.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
1 source · 60% avg. source confidence
- PR Newswire — Cradle's AI protein engineering platform serves six of top 25 pharma leaders60% source confidence
Dependency Map
What Cradle depends on below, and who depends on Cradle above — click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Cradle's Timeline
A sourced, dated history of Cradle's key moments — founding to present.
Jan 2021 · Founded
Cradle was founded to build AI-powered protein engineering software for biotech and pharma R&D teams.
Nov 2024 · Raises $73M Series B
Cradle raised a $73 million Series B round to advance its AI protein engineering software platform.